Blue Horseshoe Stocks

More Pharma Winners

Pharma Updates

Ocular Therapeutics, Inc. OCUL – We’ve been observing OCUL for a couple months now, beginning with our report from Dec. 30th. The stock did rise considerably in a predictable pattern over the first two months of 2020, and thanks largely in part to the effect the coronavirus is having on many pharma plays, the stock really kicked the increases into high gear this week.

Subsequent to our report just prior to the New Year, OCUL was trading for a little as 3.83 a share, and its new high yesterday came in at 7.48, marking a solid rise of 95%
_____

Inovio Pharmaceuticals, Inc. INO – We signaled INO on Thursday morning, and provided an update again in yesterday’s report. From its low of 3.83, we have now witnessed an upswing of 145% as of the stock’s new high of 9.40 achieved yesterday.

The markets have begun to swing back and forth with just the kind of volatility that we relish, but it is highly unlikely that we are seeing the last of the coronavirus’ effect on stocks in general. With the outbreak not yet contained, it stands to reason that this volatility will persist for the foreseeable future.

Campbell Soup Co. CPB – Options Update

We offered up an options idea for the Campbell’s chain yesterday, the CPB Weekly $49-50.50 Calls. While the 49.50’s didn’t trade substantial volume, the other three contract sets in the range saw some nice moves.

CPB Weekly $49-50.50 Calls
$49: 2.03-3.10 (+53%)
$50: 1.25-2.58 (+106%)
$50.50: .98-2.10 (+114%)

Fresh Options Ideas:
VIPS Weekly $13.50-14.50 Calls
MRVL Weekly $23.50-25 Calls
SPLK Weekly $152.50-149 Puts

Extended Watchlist:
HRAL, ARYC, SPOM, NVNT, IQST, ABML

INO Update & More

Inovio Pharmaceuticals, Inc. INO

We signaled INO on Thursday morning, and this week, the stock has enjoyed some really solid activity, which facilitated the chance at a big gain for traders. We have observed a range of 3.83-7.48 in just a couple of sessions. That works out to total potential profit of 95%

It was a buck of the overall trend as many of these pharma plays have been doing through the coronavirus scare currently in progress. While the markets got a momentary boost from the Fed’s surprise rate cut yesterday, it was not long-lived, and the decline for other stocks continued throughout the majority of the session.

This morning, the stock has hit 8.80 in the premarket, extending our observed gain this week to 130%

While world governments rush to contain the spread of the virus, it would not yet be accurate to call it under control. We would expect much more hardship on the day-to-day for stocks before we’re out of the woods. So plays like INO are a welcome respite during this tumultuous time, and we’ll do our best to keep them coming.

Fresh Options Ideas
CPB Weekly $49-50.50 Calls
JWN Weekly $32.50-30 Puts

Extended Watchlist:
LLIT, NVNT, SPOM, TLRY, TOMZ

Multi-Bag Options Runners

SPDR S&P500 (ETF) SPY – Review

We really couldn’t have timed our call of the market reversal any better, and in fact, our handling of the whole coronavirus issue has been extremely fortuitous by all accounts. Our targets, the
SPY 03/13 $298-301 Calls, were able to see some excellent new highs on the strength of the rebounding market.

The following gains represent the lows subsequent to Friday’s call of these plays to the new highs recorded yesterday:

SPY 03/13 $298-301 Calls
$298: 5.67-14.21 (+151%)
$299: 5.44-13.97 (+157%)
$300: 4.65-13.42 (+187%)
$301: 4.54-12.47 (+175%)

JD.com, Inc. JD

We also had the JD Weekly $39.50-41.50 Calls, which we offered up fresh for yesterday’s report. Despite China fears abounding, this Chinese retailer dropped solid earnings and performed exceedingly well on the day.

All of our target contracts enjoyed significant multibag moves on the day.

JD Weekly $39.50-41.50 Calls
$39.50: 1.91-4.60 (+136%)
$40: 1.55-4.17 (+169%)
$40.50: 1.30-3.60 (+177%)
$41: 1.02-3.40 (+233%)
$41.50: .85-2.75 (+224%)

We’ll roll up to the JD Weekly $42.50-43.50 Calls to stay closer to the action as we head into the midweek point.
_____

Fresh Ideas:
KSS Weekly $39.50-41.50 Calls
TGT Weekly $109-111 Calls

Extended Watchlist:
CHK, CVGW, SBBP, IPIX,

Expertly Timed Reversal

iBio, Inc. IBIO – Recap

Among those stocks that we have been tracking concurrently with the coronavirus outbreak in progress, is IBIO, which we just updated readers on in Friday morning’s report. We may be in line to see a better performance from stocks in general in contrast to last week’s historical market decline, which would lead to consolidation in stocks like IBIO, although it did manage to record an incredible new high Friday.

We had just recapped Thursday’s performance wherein the stock ran as high as .887, but Friday’s session took it to a whole new level. IBIO traded in a range from 1.50-3.40 for an intraday pop of 127%

Following our tag on Dec. 5th, the stock was trading for as little .189, and from there, Friday’s newly registered high represents an increase of 1699%

Innovation Pharmaceuticals, Inc. IPIX

We also want to watch IPIX, an OTCQB company which believes it has a scientific basis to believe that one of its preexisting treatments could be effective against coronavirus. We would suggest you read the PR outlining this in greater detail and keep IPIX on your radars. (>>View PR)

SPDR S&P500 (ETF) SPY

We also want to recap the performance of the SPY Calls we signaled on Friday morning, which will also continue to be in play for a potential market recovery this week.

We timed our flip-flop perfectly, having gone primarily with puts for our options ideas while the markets were in hysterics, and an intraday rebound provided for the following gain opportunities:

SPY 03/13 $298-301 Calls
$298: 5.67-9.41 (+66%)
$299: 5.44-8.45 (+55%)
$300: 4.65-9.32 (+100%)
$301: 4.54-9.00 (+98%)

Fresh Options Ideas:
JD Weekly $39.50-41.50 Calls

MTDR 04/17 $10-15 Calls
(Stock itself may be in play, extremely oversold)

Extended Watchlist:
MATN, WARM, TRFN, PUBC

New Highs to Report

More New Highs for Biotechs

Essentially every play we’ve been tracking that is in any way related to medical/biotech have been setting new highs as fast as we can update them. The coronavirus hysteria, along with an underlying need for a market correction is producing some incredible effects. Here are the new highs on such stocks on our watchlist.

Co-Diagnostic Inc. CODX – As we were mentioning yesterday, we’ve been on the trail of CODX since the end of last month, at which time we observed a low of 1.52. Yesterday, just as we cautioned it would, the stock reached as high as 19.67. That extends our observed range on this play to 1194%
_____

Vaxart Inc. VXRT – Another coronavirus play we’ve been watching has been VXRT, beginning on January 31st at a low of .956, and there is an impressive new high to report here as well,. The stock hit 3.40 yesterday, which brings our total possible gains on VXRT to 256%
_____

iBio, Inc. IBIO – Lastly, is a stock we placed on watch just a shade under three months ago, in IBIO. Subsequent to our tag on 12/05, we observed a low of .189 in IBIO, which has given way to a new high of .887 this week as viral virus fears continue to sweep the investment community. That represents a gain of 369%

______

Fresh Options Ideas:
SPY 03/13 $298-301 Calls